Cargando…
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3
BACKGROUND: Activation of peroxisome proliferator-activated receptors γ (PPARγ) induces diverse effects on cancer cells. The thiazolidinediones (TZDs), such as troglitazone and ciglitazone, are PPARγ agonists exhibiting antitumor activities; however, the underlying mechanism remains inconclusive. Ro...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268944/ https://www.ncbi.nlm.nih.gov/pubmed/18261208 http://dx.doi.org/10.1186/1471-2407-8-47 |